Equifax (NYSE:EFX - Get Free Report) had its price objective raised by analysts at BMO Capital Markets from $175.00 to $186.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a "market perform" rating on the credit services provider's stock. BMO Capital Markets's price objective would indicate a potential downside of 0.01% from the company's previous close.
Several other equities research analysts have also recently weighed in on EFX. Morgan Stanley decreased their price objective on Equifax from $225.00 to $205.00 and set an "overweight" rating for the company in a report on Tuesday, October 13th. Credit Suisse Group set a $160.00 target price on shares of Equifax in a report on Wednesday, September 30th. Needham & Company LLC upped their target price on shares of Equifax from $210.00 to $220.00 and gave the stock a "buy" rating in a research report on Monday. Weiss Ratings reiterated a "hold (c-)" rating on shares of Equifax in a research note on Wednesday, November 11th. Finally, Deutsche Bank reissued a "buy" rating and set a $201.00 price target on shares of Equifax in a research report on Wednesday, October 21st. Fourteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $202.73.
Get Our Latest Analysis on Equifax
Equifax Trading Down 1.8%
NYSE EFX traded down $3.49 during trading hours on Tuesday, reaching $186.01. The company's stock had a trading volume of 47,354 shares, compared to its average volume of 1,738,078. The firm has a fifty day simple moving average of $166.47 and a 200-day simple moving average of $176.12. The stock has a market cap of $21.77 billion, a P/E ratio of 30.07, a P/E/G ratio of 1.91 and a beta of 1.27. Equifax has a 52 week low of $137.01 and a 52 week high of $228.67. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.09 and a quick ratio of 1.09.
Equifax (NYSE:EFX - Get Free Report) last posted its earnings results on Tuesday, October 20th. The credit services provider reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $0.06. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.69 billion. Equifax had a net margin of 11.27% and a return on equity of 22.48%. The business's revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.04 EPS. Equities analysts forecast that Equifax will post 8.50 earnings per share for the current fiscal year.
Insider Transactions at Equifax
In other news, EVP John W. Gamble, Jr. sold 4,500 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $187.96, for a total transaction of $845,820.00. Following the sale, the executive vice president owned 69,055 shares in the company, valued at $12,979,577.80. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Begor sold 37,792 shares of the firm's stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $182.80, for a total transaction of $6,908,377.60. Following the sale, the chief executive officer directly owned 289,922 shares of the company's stock, valued at $52,997,741.60. This trade represents a 11.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 61,402 shares of company stock worth $11,332,342. Corporate insiders own 1.70% of the company's stock.
Institutional Trading of Equifax
Several institutional investors have recently added to or reduced their stakes in EFX. BlackRock Inc. bought a new stake in shares of Equifax in the second quarter worth approximately $1,491,357,000. Soroban Capital Partners LP raised its holdings in shares of Equifax by 310.5% during the first quarter. Soroban Capital Partners LP now owns 4,184,569 shares of the credit services provider's stock valued at $753,515,000 after purchasing an additional 3,165,120 shares during the last quarter. Generation Investment Management LLP purchased a new position in shares of Equifax during the second quarter valued at approximately $290,868,000. Bank of America Corp DE bought a new position in Equifax during the second quarter valued at approximately $187,215,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Equifax during the second quarter valued at approximately $174,843,000. 96.20% of the stock is currently owned by hedge funds and other institutional investors.
Equifax Company Profile
(
Get Free Report)
Equifax Inc. is a global data, analytics and technology company best known as one of the major consumer credit reporting agencies in the United States. The company traces its history to 1899, when it was founded as the Retail Credit Company, and adopted the Equifax name in 1975. Equifax provides consumer and business credit information, credit reports and scores, and tools for identity verification and fraud prevention. Its products also help businesses assess risk and make decisions about lending, customer relationships and marketing.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.